1 |
Zhang X, He Y, Ren P, Chen L, Han Z, Qi L, Chen L, Luo Y, Zhang N, Lu W, Guo H. Low expression and Hypermethylation of ATP2B1 in Intrahepatic Cholangiocarcinoma Correlated With Cold Tumor Microenvironment. Front Oncol 2022;12:927298. [DOI: 10.3389/fonc.2022.927298] [Reference Citation Analysis]
|
2 |
Li L, Zhong L, Tang C, Gan L, Mo T, Na J, He J, Huang Y. CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target. Clin Transl Oncol 2022. [PMID: 35165838 DOI: 10.1007/s12094-022-02792-0] [Reference Citation Analysis]
|
3 |
Tang Y, Guo C, Yang Z, Wang Y, Zhang Y, Wang D. Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma. Front Immunol 2022;13:862527. [PMID: 35493471 DOI: 10.3389/fimmu.2022.862527] [Reference Citation Analysis]
|
4 |
Ayuso-Íñigo B, Méndez-García L, Pericacho M, Muñoz-Félix JM. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement? Cancers (Basel) 2021;13:5412. [PMID: 34771575 DOI: 10.3390/cancers13215412] [Reference Citation Analysis]
|
5 |
Niu M, Yi M, Li N, Wu K, Wu K. Advances of Targeted Therapy for Hepatocellular Carcinoma. Front Oncol 2021;11:719896. [PMID: 34381735 DOI: 10.3389/fonc.2021.719896] [Reference Citation Analysis]
|
6 |
Franz L, Nicolè L, Frigo AC, Ottaviano G, Gaudioso P, Saccardo T, Visconti F, Cappellesso R, Blandamura S, Fassina A, Marioni G. Epithelial-to-Mesenchymal Transition and Neoangiogenesis in Laryngeal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3339. [PMID: 34283055 DOI: 10.3390/cancers13133339] [Reference Citation Analysis]
|